Position in NVS
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,442,607
-$41,970 QoQ
Shares Held
9,205
-5.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#514
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stratos Wealth Partners, LTD. holds $186,063,127 across 15 Drug Manufacturers - General names. NVS ranks #10 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
41,007 | $49,185,030 | |
| 2 | ABBV |
AbbVie Inc.
|
168,592 | $42,424,490 | |
| 3 | JNJ |
Johnson & Johnson
|
142,858 | $36,281,646 | |
| 4 | MRK |
Merck & Co., Inc.
|
108,575 | $13,951,887 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
202,756 | $11,682,800 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
81,521 | $10,299,363 | |
| 7 | AMGN |
Amgen Inc
|
25,957 | $9,399,548 | |
| 8 | PFE |
Pfizer Inc
|
210,188 | $5,061,327 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,442,607 | 9,205 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,484,577 | 9,719 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,321,621 | 9,586 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,318,563 | 10,282 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,104,579 | 9,128 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $1,122,492 | 10,069 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,205,184 | 12,385 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,431,883 | 12,449 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $1,421,347 | 13,351 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,200,032 | 12,406 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $1,354,310 | 13,413 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,343,125 | 13,186 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,238,872 | 12,277 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $1,189,100 | 12,925 | Shares | Sole | 2023-04-27 | |
| 2022-12-31 | $1,238,872 | 13,656 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $948,452 | 12,478 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $1,122,304 | 13,277 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,031,413 | 11,754 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $1,043,429 | 11,929 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $960,751 | 11,748 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $1,068,967 | 11,716 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $1,086,450 | 12,710 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $1,271,122 | 13,461 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,356,402 | 15,598 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $1,475,958 | 16,899 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $1,018,834 | 12,357 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||